PCHorvathAge

Biomarker

1 paper1 finding

  • Humans1

Effects

1

Hepatocellular carcinoma

no changein humans1

1 study
  1. PCHorvathAge has no effect on hepatocellular carcinoma in humans.

    “were associated with MASLD-HCC, but not PCHorvathAge or PCHannumAge”

    Humansin patients with MASLD

    Association of Epigenetic Aging Biomarkers With Risk of MASLD-Related HCC

    Liver international : official journal of the International Association for the Study of the Liver29 Nov 2025

More on Hepatocellular carcinoma

Latest

Nov 2025: 1Dec 2025: 0Jan 2026: 0Feb 2026: 0Mar 2026: 0Apr 2026: 0May 2026: 0Jun 2026: 0Jul 2026: 0Aug 2026: 0Sep 2026: 0Oct 2026: 01 in 12 months